Delivering Pharmaceutical Compounds for Novel Formulations
Developing proprietary polymer platform technologies to deliver existing pharmaceutical compounds in novel formulations for Diabetes, Orthopedics, Cancer and Infection, including Biofilm management.
Royer Biomedical, Inc. is a privately held company based outside Washington DC in Frederick, Maryland. Royer has a strong research background in Polymer chemistry and localized therapeutic systems, and holds numerous US and international patents on calcium and gel matrices capable of delivering a broad array of anti-infective, anti-neoplastic, and analgesic pharmaceuticals.
AppliGel/VetriGel and Matrix III utilize proprietary polymer platform technologies to deliver existing pharmaceutical compounds in novel formulations. These synthetic (no animal products or collagen) proprietary platforms allow for sterile delivery and controlled elution rates with controlled rates of bioresorption, without any immunogenic response, acid production during resorption, or susceptibility to proteolytic enzyme attack.